Current Market Situation and Future Trends Current market situation At present, this tablet is mainly targeted at scientific research institutions and biotechnology companies, and is used for research in fields such as inflammatory bowel disease, multiple sclerosis, and wound healing.As it has not obtained drug approval, the market size is relatively small, but the demand is on the rise
This application is based on data from the SOUL cardiovascular outcomes trial that demonstrated a 14% relative risk reduction in MACE in patients treated with Rybelsus 14 mg orally once daily for approximately five years compared to those who received placebo
Xu J, Guo H, Xing Z, Zhang W, He J, Cheng J, et al
doi: 10.1002/jnr.23764 120 MottaghiSAbbaszadehH